Oncocyte Corp financial data

Symbol
OCX on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
Location
15 Cushing, Irvine, CA
State of incorporation
CA
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 24, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 104 % -47.9%
Debt-to-equity 674 % +458%
Return On Equity -765 % -851%
Return On Assets -96.7 % -184%
Operating Margin -3.25K % -94%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 28.6M shares +246%
Common Stock, Shares, Outstanding 17.5M shares +111%
Entity Public Float 24.6M USD +30.9%
Common Stock, Value, Issued 338M USD +9.01%
Weighted Average Number of Shares Outstanding, Basic 13.1M shares +70.8%
Weighted Average Number of Shares Outstanding, Diluted 13.1M shares +70.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 1.88M USD +25.2%
Cost of Revenue 1.05M USD +5.09%
Research and Development Expense 9.84M USD +5.86%
Selling and Marketing Expense 3.94M USD +41.1%
General and Administrative Expense 10.2M USD -8.75%
Operating Income (Loss) -61M USD -143%
Nonoperating Income (Expense) 378K USD +34.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -60.7M USD -144%
Net Income (Loss) Attributable to Parent -60.7M USD -118%
Earnings Per Share, Basic -4.66 USD/shares -24.3%
Earnings Per Share, Diluted -4.66 USD/shares -24.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 8.64M USD -8.44%
Accounts Receivable, after Allowance for Credit Loss, Current 1.61M USD +233%
Inventory, Net 410K USD
Assets, Current 11.8M USD +9.92%
Property, Plant and Equipment, Net 5.98M USD +27%
Operating Lease, Right-of-Use Asset 4.04M USD +15.3%
Intangible Assets, Net (Excluding Goodwill) 14.6M USD -74.2%
Other Assets, Noncurrent 691K USD +49.2%
Assets 35.1M USD -53.2%
Accounts Payable, Current 2.28M USD +139%
Accrued Liabilities, Current 1.94M USD +17.6%
Liabilities, Current 7.28M USD +1.13%
Liabilities 47.4M USD -3.94%
Accumulated Other Comprehensive Income (Loss), Net of Tax 21K USD -57.1%
Retained Earnings (Accumulated Deficit) -351M USD -20.9%
Stockholders' Equity Attributable to Parent -12.3M USD -160%
Liabilities and Equity 35.1M USD -53.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.83M USD +53.9%
Net Cash Provided by (Used in) Financing Activities -28K USD +92.1%
Net Cash Provided by (Used in) Investing Activities -24K USD +98.3%
Common Stock, Shares Authorized 230M shares 0%
Common Stock, Shares, Issued 17.5M shares +111%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.85M USD +60.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 19.1M USD -59%
Deferred Tax Assets, Valuation Allowance 64.4M USD -4.28%
Deferred Tax Assets, Gross 69.1M USD -16.4%
Operating Lease, Liability 2.63M USD
Depreciation 450K USD +56.8%
Payments to Acquire Property, Plant, and Equipment 24K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -60.7M USD -119%
Lessee, Operating Lease, Liability, to be Paid 3.02M USD -10.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.18M USD +36%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.14M USD +26.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 394K USD -38.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 695K USD -22.7%
Deferred Tax Assets, Operating Loss Carryforwards 50M USD -19.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 1.09M USD -52.7%
Lessee, Operating Lease, Liability, to be Paid, Year Four 695K USD -22.7%
Operating Lease, Payments 272K USD -4.9%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 88K USD 0%
Deferred Tax Assets, Net of Valuation Allowance 4.68M USD -69.5%
Share-based Payment Arrangement, Expense 1.75M USD -36.5%